Psilocybin could aid patients with cancer and depression, new study suggests
Sunstone Therapies published data from a small Phase II trial highlighting potential benefits of psilocybin therapy in cancer and depression.
Cerba Research WP
Quadriga doses first breast cancer patient in Phase II trial
AstraZeneca reports positive data from ovarian cancer combo therapy trial
Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Keytruda plus chemotherapy reduce risk of endometrial cancer
Pfizer and Astellas report positive data from prostate cancer therapy trial
Targovax announces dosing of first subject with TG01 for pancreatic cancer
Positive data for PD-1 inhibitors in gastric cancer, but who can compete with Opdivo?
